Effectiveness of Prescription CBD for Epilepsy May Wane in a Quarter of Patients
Approximately 25 percent of drug-resistant epilepsy patients taking cannabidiol (CBD) developed a tolerance to the treatment, researchers said at the American Epilepsy Society annual meeting taking place Nov.30 – Dec. 4, 2018. The findings suggest that that the effectiveness of the CBD drug might wane in the long term forRead
